ADRIENNE MOODY: Open Payments
NPI 1336505320 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 63 payments from 27 companies in 2025. Trend: 2023 $234 · 2024 $396 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 9 | $170 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| BeOne Medicines USA, Inc. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 3 | $72 |
| PFIZER INC. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Janssen Biotech, Inc. | 2 | $46 |
| Incyte Corporation | 2 | $44 |
Products named: KEYTRUDA, IMFINZI, KISQALI, BRUKINSA, ORGOVYX, PLUVICTO, XTANDI, JAKAFI.
Industry payments across AL — which companies pay providers there.
